GCAP1 Antibodies

Santa Cruz Biotechnology features a diverse variety of GCAP1 monoclonal antibodies for research focused on Guanylate Cyclase Activating Protein 1 (GCAP1). Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GCAP1 is a calcium-binding protein that plays a crucial role in the regulation of phototransduction in retinal photoreceptors. By modulating the activity of guanylate cyclase, GCAP1 is essential for maintaining the balance of cyclic GMP levels, which is vital for normal vision. Understanding GCAP1 function provides insights into retinal disease mechanisms and potential therapeutic approaches. Research applications include studying GCAP1 expression patterns, protein interactions, and cellular localization in vision science. Investigating GCAP1 signaling pathways helps reveal its role in photoreceptor function and retinal health. GCAP1 research contributes to understanding calcium-dependent regulation in visual processing. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance vision science and contribute to developing new therapeutic strategies for retinal disorders.